Difference between revisions of "WSI21-76-Case-3"
From MGH Learn Pathology
(Automatic edit to upgrade to new templates) |
(Updating subject, access, and performer) |
||
| Line 10: | Line 10: | ||
|supportingInfo=Methotrexate-induced transient myelosuppression and dysplasia | |supportingInfo=Methotrexate-induced transient myelosuppression and dysplasia | ||
|reasonCode=82 year-old female with history of chronic renal failure due to autoimmune disease; previous anemia of chronic disease on EPO therapy, now has become leukopenic and thrombocytopenic. WBC 0.6 x 109/L (23% polys, 66% lymphs, 11% eos), HGB 6.7 g/dL, PLT 13 x 109/L. | |reasonCode=82 year-old female with history of chronic renal failure due to autoimmune disease; previous anemia of chronic disease on EPO therapy, now has become leukopenic and thrombocytopenic. WBC 0.6 x 109/L (23% polys, 66% lymphs, 11% eos), HGB 6.7 g/dL, PLT 13 x 109/L. | ||
| − | |subject= | + | |subject=MGH |
| − | |performer= | + | |performer=RH27 |
|authoredOn=April 12, 2021 08:40:24 PM | |authoredOn=April 12, 2021 08:40:24 PM | ||
|requester=Rh27 | |requester=Rh27 | ||
|sequence=3 | |sequence=3 | ||
| + | |access=public | ||
}} | }} | ||
{{Media | {{Media | ||
Revision as of 15:02, June 21, 2022
